BioInquire Overview
- Year Founded
-
2006
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
BioInquire General Information
Description
Developer of a bioinformatics analysis platform designed to help researchers analyze mass spectrometric data from proteomic and glycomic experiments. The company's platform offers a comprehensive suite of tools that provides support throughout the full data analysis pipeline, from statistical validation to quantification, enabling researchers to derive meaningful data from the massive amounts of information generated by complex proteomic and glycomic experiments.
Contact Information
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Business/Productivity Software
Primary Office
- 220 Riverbend Road
- Suite 103
- Athens, GA 30602
- United States
BioInquire Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 04-Sep-2012 | Completed | Out of Business | |||
| 2. Later Stage VC | 01-Mar-2023 | Completed | Profitable | |||
| 1. Merger/Acquisition | 17-Feb-2010 | $3M | 000 | Completed | Profitable |